Juan I. Ruiz, MD, MPH

Peer-Reviewed Articles

1. Ruiz JI,, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review. J Immunother Precis Oncol 6(2):103-110, 2023. e-Pub 2023. PMID: 37214207.
2. Maria A. Lopez-Olivo 1, Gabrielle F. Duhon, Juan I. Ruiz, Mehmet Altan, Hussein Tawbi, Adi Diab, Clifton O. Bingham III ,Cassandra Calabrese ,Natalia I. Heredia,Robert J. Volk and Maria E. Suarez-Almazor. Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study. Multidisciplinary Digital Publishing Institute, 2023.
3. Bergese S, Fox B, García-Allende N, Elisiri ME, Schneider AE, Ruiz JI, Gonzalez-Fraga S, Rodriguez V, Fernandez-Canigia L. Impact of the multiplex molecular FilmArray Respiratory Panel on antibiotic prescription and clinical management of immunocompromised adults with suspected acute respiratory tract infections: A retrospective before-after study. Rev Argent Microbiol. e-Pub 2023. PMID: 37127474.
4. Ruiz JI, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis. J Immunother Cancer 11(2), 2023. PMID: 36746512.
5. Ruiz JI, Singh G, Erck M, Geng Y, Suarez-Almazor ME, Lopez-Olivo MA. Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan. PLoS One 17(10):e0275676, 2022. e-Pub 2022. PMID: 36215234.
6. Rodríguez V, Machiavello D, Spira C,Ruiz JI, Canteros F, Roberti J, Belizán M, García-Elorrio E. Adaptation and implementation of the Batz guide for bedside advocacy in two hospitals. Int J Risk Saf Med. e-Pub 2021. PMID: 34924403.
7. Clavijo MM, Vicente Reparaz MLA, Ruiz JI, Acuña MA, Casali CE, Aizpurua MF, Mahuad CV, Eciolaza S, Ventura A, Garate GM. Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism. Cureus 13(9):e18236, 2021. e-Pub 2021. PMID: 34722035.
8. McDaniel JT, Nuhu K, Ruiz JI, Alorbi G. Social determinants of cancer incidence and mortality around the world: an ecological study. Glob Health Promot 26(1):41-49, 2019. e-Pub 2017. PMID: 29187122.
9. Nuhu KM, McDaniel JT, Alorbi GA, Ruiz JI. Effect of healthcare spending on the relationship between the Human Development Index and maternal and neonatal mortality. International health, 2018.
10. Ruiz JI, Nuhu K, McDaniel JT, Popoff F, Izcovich A, Criniti JM. Inequality as a Powerful Predictor of Infant and Maternal Mortality around the World. PLoS One 10(10):e0140796, 2015. e-Pub 2015. PMID: 26488170.
11. Nuhu K, McDaniel JT, Ruiz JI. Socioeconomic Distribution and Behavior: A Comparative Analysis of Urban and Rural Counties in the USA. Epidemiology Biostatistcs and Public Health, 2015.
12. Nuhu K, McDaniel JT, Ruiz JI. Colorectal Cancer, Socioeconomic Distribution and Behavior: A Comparative Analysis of Urban and Rural Counties in the USA. Epidemiology Biostatistcs and Public Health, 2015.
13. Izcovich A, Criniti JM, Ruiz JI, Catalano HN. Impact of a GRADE-based medical question answering system on physician behaviour: a randomised controlled trial. Evidence Based Medicine, 2015.
14. Criniti JM, Izcovich A, Popoff F, Ruiz JI, Catalano HN. [Ticagrelor in acute coronary syndrome. Explaining the inexplicable]. Medicina (B Aires) 74(3):239-44, 2014. PMID: 24918677.
15. Anders M, González VM, Ruiz JI, Casas G, Goldaracena N, Orozco F, Antinucci F, Larralde M, Catalano H, Quifionez E, McCormack L, Mastai R. An unreported case of pancreatic panniculitis in a liver transplant patient. Acta Gastroenterol Latinoam 44(3):239-42, 2014. PMID: 26742296.
16. Furio A, Fontao R, Falco N, Ruiz JI, Cardinali DP. Neuroprotective Effect of Melatonin on Glucocorticoid Toxicity in the Rat Hippocampus. The Open Physiology Journal, 2008.

Manuals, Teaching Aids, Other Teaching Publications

1. Ruiz JI, Izcovich A, Catalano HN. Resolución de problemas clínicos basada en las mejores pruebas. PROAMI - Editorial Medica Panamericana: Argentina, 2014.
2. Ruiz JI, Gómez EJ, González Malla C, Catalano HN. Miastenia Gravis: Diagnóstico y Opciones Terapéuticas. Oportunidad Quirúrgica. PROAMI - Editorial Medica Panamericana: Argentina, 2010.

Abstracts

1. Ruiz JI, Wu C, Zhao H, Giordano S, Rajan S, Suarez-Almazor M.. Utilization of Biologic and Targeted Disease Modifying Antirheumatic Therapy in Patients with Rheumatoid Arthritis and Breast Cancer [abstract]. Arthritis Rheumatol 74(9), 2022. e-Pub 2022.
2. Lopez-Olivo M, Kachira J, Buni M, Kim S, Lu H, Duhon G, Ruiz J, Bingham III C, Calabrese C, Volk R, Suarez-Almazor M.. Learning Needs Assessment for Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors. Arthritis Rheumatol 74(9), 2022. e-Pub 2022.
3. Lopez-Olivo M, Kachira J, Buni M, Kim S, Lu H, Duhon G, Ruiz JI, Bingham III C, Calabrese C, Volk R, Suarez-Almazor M.. Learning Needs Assessment for Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors [abstract]. Arthritis Rheumatol 74(9), 2022. e-Pub 2022.
4. Ruiz JI, et al. PCN519 Real World Evidence (RWE): Analysis of the prognosis of patients with metastatic colon cancer under biologic treatment in the social security sector of Argentina. Value in Health 22 (2019): S539, 2019.
5. Ruiz JI, Izcovich A, González Malla C, Esandi ME, Raineri F, Chapman E, Catalano HN. Using the GRADE Approach to Support the Development of Public Health Policies: an Innovative experience from Argentina. Newsletter of the International Society for Evidence-Based Health Care, 2016.
6. Ruiz JI, Navar SM, Failo A, Catalano HN. Perceptions and Attitudes of Medical Students towards Evidence Based Physical Examination Teaching: A Qualitative Study. Newsletter of the International Society for Evidence-Based Health Care, 2016.
7. Manzano JG, Franco-Vega, M, Lu M, Sahar H, Leal-Alviarez D, Altay H, Ruiz JI, Tomy S, Brito-Dellan N.. Enhancing the Coordination of Care for Hospitalized Patients with Suspected Immune Checkpoint Inhibitor (ICI)-related Pneumonitis through the Development and Implementation of a Hospital-Based Clinical Care Pathway.